NCT05792930 Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder
| NCT ID | NCT05792930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Somatic Symptom Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-07-11 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-07-11 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research program is aimed to develop a integrative psychotherapy (including CBT and biofeedback therapy) and to examine its efficacy on treatment of somatic symptom disorder. The study design is a randomized controlled trial with waiting list control. Scores of Patient Health Questionniare-15 and Health Anxiety Questionnaire are the primary endpoints.
Eligibility Criteria
Inclusion Criteria: * Patient with somatic symptom disorder (confirmed by psychiatrists) Exclusion Criteria: * The age is younger than 20 or older than 70 years * Having psychotic symptoms or cognitive impairment * Having a potentially lethal illness * Cannot read the questionnaires by oneself
Contact & Investigator
Wei-Lieh Huang, MD, PhD
PRINCIPAL INVESTIGATOR
National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT05792930 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Somatic Symptom Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05792930 currently recruiting?
Yes, NCT05792930 is actively recruiting participants. Contact the research team at weiliehhuang@gmail.com for enrollment information.
Where is the NCT05792930 trial being conducted?
This trial is being conducted at Yunlin, Taiwan.
Who is sponsoring the NCT05792930 clinical trial?
NCT05792930 is sponsored by National Taiwan University Hospital. The principal investigator is Wei-Lieh Huang, MD, PhD at National Taiwan University Hospital. The trial plans to enroll 60 participants.